Merck & Co., Inc. is 184.7x more valuable than PRECIGEN, INC. by market capitalization ($298.26 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGEN | MRK |
|---|---|---|
| Market cap | $1.61 B | $298.26 B |
| US-listed rank | #2268 | #45 |
| Revenue (latest FY) | $9.68M | $65.01B |
| Net income (latest FY) | -$250.60M | $18.25B |
| Net margin | -2587.8% | 28.1% |
| P/E (trailing FY) | - | 16.3 |
| SEC filings | 1,273 | 996 |
Merck & Co., Inc. is 184.7x more valuable than PRECIGEN, INC. by market capitalization ($298.26 B vs $1.61 B).
In their latest fiscal years, PRECIGEN, INC. reported $9.68M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: PRECIGEN, INC. and Merck & Co., Inc., or browse the full rankings.